QWM
SRPT icon

Quaker Wealth Management’s Sarepta Therapeutics SRPT Stock Holding History

Quaker Wealth Management’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-403
Closed -$25.7K – 1602
2025
Q1 		$25.7K Buy
+403
New +$42.4K 0.01% 218

Other funds holding SRPT

EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
GIC
Generali Investments CEE Prague, Czech Republic $2.11B AUM 25.53% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
OAM
OP Asset Management Helsinki $9.38B AUM 42.35% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
DT
Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return
LSERS
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

Quaker Wealth Management's SRPT Position: Q2 2026 in Review

Quaker Wealth Management held its Sarepta Therapeutics (SRPT) position steady in Q2 2026 at 400 shares worth $7.19K. The position accounts for ﹤0.01% of the portfolio, ranked #311.

Quaker Wealth Management first reported a position in SRPT in Q2 2025 and has held it in 5 quarters since. The position peaked at $8.7K in Q1 2026. 57 funds tracked by Wall St. Rank hold SRPT as of Q2 2026.

  • Quaker Wealth Management held 400 shares of Sarepta Therapeutics worth $7.19K as of Q2 2026.
  • Quaker Wealth Management left its Sarepta Therapeutics share count unchanged in Q2 2026.
  • Sarepta Therapeutics made up ﹤0.01% of Quaker Wealth Management's portfolio in Q2 2026, its #311 holding.
  • Quaker Wealth Management first reported a position in Sarepta Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • Quaker Wealth Management's Sarepta Therapeutics position peaked at $8.7K in Q1 2026.
  • 57 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2026.

Based on Quaker Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.